5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
Non-Muscle Invasive Bladder Cancer, Pembro Approval and New agents Oportuzumab Monatox and Nadofaragene Firadenovec
Comments 0
Login to view comments.
Click here to Login